A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT01168310 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

468

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Fluticasone Propionate/Formoterol Fumarate
DRUG: Fluticasone Propionate/Formoterol Fumarate
DRUG: Fluticasone Propionate/Formoterol Fumarate
DRUG: Fluticasone Propionate/Formoterol Fumarate
DRUG: Fluticasone Propionate/Formoterol Fumarate
DRUG: Formoterol Fumarate
DRUG: Placebo

Sponsor

Dey